Reviva Pharmaceuticals Holdings Inc (RVPHW) — Cash Flow-to-Debt Ratio
Reviva Pharmaceuticals Holdings Inc (RVPHW) has a Cash Flow-to-Debt Ratio of -0.57x as of September 2025, meaning its operating cash flow of $-5.59 Million could theoretically repay -1% of its total liabilities ($9.78 Million) in one year. See RVPHW financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Reviva Pharmaceuticals Holdings Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Reviva Pharmaceuticals Holdings Inc across 7 annual periods. For the full cash flow conversion analysis, see RVPHW cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Reviva Pharmaceuticals Holdings Inc (2018–2024)
Year-by-year debt coverage analysis for Reviva Pharmaceuticals Holdings Inc. Check Reviva Pharmaceuticals Holdings Inc (RVPHW) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.28x | $-33.54 Million | $14.69 Million | ▼ -45.0% |
| 2023 | -1.58x | $-28.32 Million | $17.98 Million | ▲ +12.5% |
| 2022 | -1.80x | $-18.96 Million | $10.53 Million | ▲ +54.1% |
| 2021 | -3.93x | $-10.67 Million | $2.72 Million | ▼ -218.2% |
| 2020 | -1.23x | $-4.07 Million | $3.30 Million | ▼ -3748.1% |
| 2019 | -0.03x | $-218.44K | $6.81 Million | ▲ +81.8% |
| 2018 | -0.18x | $-1.07 Million | $6.09 Million | — |